Please indicate your professional title: *

MD/DO

PA

NP

RN

PhD

PharmD

Other, please specify:

Please indicate your professional title: Other, please specify:

How many years have you been in practice? *

0-5

6-10

11-15

More than 15

How many patients do you manage weekly? *

0-25

26-50

51-75

76-100

More than 100

Please evaluate by marking the appropriate response: *

	Poor	Fair	Good	Excellent
Quality of educational content	Quality of educational content - Poor	Quality of educational content - Fair	Quality of educational content - Good	Quality of educational content - Excellent
Scientific Integrity	Scientific Integrity - Poor	Scientific Integrity - Fair	Scientific Integrity - Good	Scientific Integrity - Excellent
Faculty effectively conveyed the subject matter	Faculty effectively conveyed the subject matter - Poor	Faculty effectively conveyed the subject matter - Fair	Faculty effectively conveyed the subject matter - Good	Faculty effectively conveyed the subject matter - Excellent
Relevance to My Practice	Relevance to My Practice - Poor	Relevance to My Practice - Fair	Relevance to My Practice - Good	Relevance to My Practice - Excellent
Appropriate Level of Difficulty	Appropriate Level of Difficulty - Poor	Appropriate Level of Difficulty - Fair	Appropriate Level of Difficulty - Good	Appropriate Level of Difficulty - Excellent
Overall Rating	Overall Rating - Poor	Overall Rating - Fair	Overall Rating - Good	Overall Rating - Excellent
Objectivity and balance	Objectivity and balance - Poor	Objectivity and balance - Fair	Objectivity and balance - Good	Objectivity and balance - Excellent

Was this activity free from commercial bias? *

Yes

No

Please provide more detail about the bias observed. *

Please rate whether this program achieved the following learning objectives: *

	Strongly disagree	Disagree	Agree	Strongly Agree
Increase healthcare providers' knowledge and understanding of biosimilars, including their development, regulatory approval, and differences from reference biologic drugs.	Increase healthcare providers' knowledge and understanding of biosimilars, including their development, regulatory approval, and differences from reference biologic drugs. - Strongly disagree	Increase healthcare providers' knowledge and understanding of biosimilars, including their development, regulatory approval, and differences from reference biologic drugs. - Disagree	Increase healthcare providers' knowledge and understanding of biosimilars, including their development, regulatory approval, and differences from reference biologic drugs. - Agree	Increase healthcare providers' knowledge and understanding of biosimilars, including their development, regulatory approval, and differences from reference biologic drugs. - Strongly Agree
Enhance providers' confidence in prescribing biosimilars by presenting current evidence on their safety, efficacy, and immunogenicity.	Enhance providers' confidence in prescribing biosimilars by presenting current evidence on their safety, efficacy, and immunogenicity. - Strongly disagree	Enhance providers' confidence in prescribing biosimilars by presenting current evidence on their safety, efficacy, and immunogenicity. - Disagree	Enhance providers' confidence in prescribing biosimilars by presenting current evidence on their safety, efficacy, and immunogenicity. - Agree	Enhance providers' confidence in prescribing biosimilars by presenting current evidence on their safety, efficacy, and immunogenicity. - Strongly Agree
Improve providers' skills in communicating with patients about biosimilars, addressing patient concerns, and supporting informed decision-making regarding biosimilar treatment options.	Improve providers' skills in communicating with patients about biosimilars, addressing patient concerns, and supporting informed decision-making regarding biosimilar treatment options. - Strongly disagree	Improve providers' skills in communicating with patients about biosimilars, addressing patient concerns, and supporting informed decision-making regarding biosimilar treatment options. - Disagree	Improve providers' skills in communicating with patients about biosimilars, addressing patient concerns, and supporting informed decision-making regarding biosimilar treatment options. - Agree	Improve providers' skills in communicating with patients about biosimilars, addressing patient concerns, and supporting informed decision-making regarding biosimilar treatment options. - Strongly Agree

This activity will assist in the improvement of my: *

Select all that apply

Knowledge

Competence (e.g. knowing how to do something)

Performance (e.g. what actions are taken, skills, strategies and abilities implemented into practice)

Patient outcomes (e.g. improvements in patient care and individual health status)

None; this activity validated my practice

How confident are you now in your ability to prescribe biosimilars using current evidence on their safety, efficacy, and immunogenicity?? *

Not at all confident

Slightly confident

Moderately confident

Very confident

Which of the following tools/resources included in this activity do you plan to use? *

Select all that apply

[Paste in name of tool 1]

[Paste in name of tool 2]

[Paste in name of tool 3]

Please identify what changes you will make as a result of participating in this activity? *

Select all that apply

Incorporate current evidence on biosimilars into my clinical decision-making.

Improve how I identify and address biosimilar differences from reference biologic drugs.

Use evidence-based biosimilar information to counsel patients, address questions, and support informed decision making regarding biosimilar treatment options.

No changes will be made; this activity validated my practice

Not applicable; I do not provide patient care or biosimilars related counseling in my current role.

Other, please specify...

Please identify what changes you will make as a result of participating in this activity? Other, please specify...

What barriers, if any, may prevent you from implementing what you learned: *

Select all apply

Insurance coverage/cost

Lack of access to therapies/resources

Lack of evidence-based guidelines

Lack of time

Limited staff capacity

Patient adherence

Organizational/institutional policies

No barriers anticipated

Not applicable; I don't see patients with the condition discussed or I don't see patients in my current position

Other, please specify:

What barriers, if any, may prevent you from implementing what you learned: Other, please specify:

What is one pearl you took away as a result of your participation?

Leave this field blank